Prevalence of TT virus in patients with fulminant hepatic failure in Japan

Journal of Gastroenterology

Volumn 34, Issue 5, 1999, Pages 589-593

  Tanaka, Motoharu ^a   Nishiguchi, Shuhei ^a   Tanaka, Takashi ^a   Enomoto, Masaru ^a   Takeda, Tadashi ^a   Shiomi, Susumu ^a   Kuroki, Tetsuo ^a   Otani, Shuzo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Fulminant hepatic failure; Hepatitis virus; TT virus

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; COMA; CONTROLLED STUDY; DNA VIRUS; FEMALE; GENOTYPE; HEPATITIS VIRUS; HUMAN; LABORATORY TEST; LIVER FAILURE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; VIRUS INFECTION; VIRUS ISOLATION;

ADOLESCENT; ADULT; AGED; DNA VIRUS INFECTIONS; DNA VIRUSES; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS ANTIBODIES; HUMANS; JAPAN; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 0032734848     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050377     Document Type: Article

References (13)

1. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis 1970;3:282-98.
2. Williams R. Classification, etiology, and considerations of outcome in acute liver failure. Semin Liver Dis 1996;16:343-8.
3. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995;346:1131-2.
4. Alter HJ. The cloning and clinical implications of GBV-C/GBV-C/HGV and HGBV-C. N Engl J Med 1996;334:1536-7.
5. Kuroki T, Nishiguchi S, Tanaka M, Enomoto M, Kobayashi K. Does GBV-C cause fulminant hepatitis in Japan? Lancet 1996; 347:908.
6. Tanaka M, Nishiguchi S, Tanaka T, Enomoto M, Fukuda K, Takeda T, et al. Prevalence of GBV-C and hepatitis G virus variants in patients with fulminant hepatic failure in Japan. J Hepatol 1997;27:966-72.
7. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997;241: 92-7.
8. Okamoto H, Nishizawa T, Kato N, Ukita M, Ikeda H, Iizuka H, et al. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res 1998;10:1-16.
9. Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990;64:1298-303.
10. Nishiguchi S, Kuroki T, Ueda T, Fukuda K, Takeda T, Nakajima S, et al. Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis. Ann Intern Med 1992;116:21-5.
11. Reyes GR, Purdy MA, Kim JP, Luk K-C, Young LM, Fry KE, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990;247:1335-9.
12. Kwork S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237-8 [Erratum, Nature 1989;339:490].
13. Enomoto M, Nishiguchi S, Fukuda K, Kuroki T, Tanaka M, Otani S, et al. Characteristics of patients with hepatitis C virus with and without GB virus C/hepatitis G virus coinfection, and efficacy of interferon alpha. Hepatology 1998;27:1388-93.